312 related articles for article (PubMed ID: 3501355)
1. Enzyme immunoassays for the detection of IgG and IgM anti-dsDNA antibodies: clinical significance and specificity.
Tzioufas AG; Manoussakis MN; Drosos AA; Silis G; Gharavi AE; Moutsopoulos HM
Clin Exp Rheumatol; 1987; 5(3):247-53. PubMed ID: 3501355
[TBL] [Abstract][Full Text] [Related]
2. Anti-DNA, anti-deoxyribonucleoprotein and rheumatoid factor measured by ELISA in patients with systemic lupus erythematosus, Sjögren's syndrome and rheumatoid arthritis.
Karsh J; Halbert SP; Anken M; Klima E; Steinberg AD
Int Arch Allergy Appl Immunol; 1982; 68(1):60-9. PubMed ID: 6978853
[TBL] [Abstract][Full Text] [Related]
3. IgM anti-dsDNA antibodies in systemic lupus erythematosus: negative association with nephritis. SLE Study Group.
Witte T; Hartung K; Sachse C; Matthias T; Fricke M; Deicher H; Kalden JR; Lakomek HJ; Peter HH; Schmidt RE
Rheumatol Int; 1998; 18(3):85-91. PubMed ID: 9833247
[TBL] [Abstract][Full Text] [Related]
4. Antibodies to histones of the IgG and IgM class in systemic lupus erythematosus.
Krippner H; Springer B; Merle S; Pirlet K
Clin Exp Immunol; 1984 Oct; 58(1):49-56. PubMed ID: 6332696
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of anti-dsDNA antibody isotypes: IgG/IgM ratio of anti-dsDNA antibodies as a prognostic marker for lupus nephritis.
Förger F; Matthias T; Oppermann M; Becker H; Helmke K
Lupus; 2004; 13(1):36-44. PubMed ID: 14870916
[TBL] [Abstract][Full Text] [Related]
6. What is the clinical significance of anti-Sm antibodies in systemic lupus erythematosus? A comparison with anti-dsDNA antibodies and C3.
Flechsig A; Rose T; Barkhudarova F; Strauss R; Klotsche J; Dähnrich C; Schlumberger W; Enghard P; Burmester GR; Hiepe F; Biesen R
Clin Exp Rheumatol; 2017; 35(4):598-606. PubMed ID: 28281463
[TBL] [Abstract][Full Text] [Related]
7. [The autoantibody profile and disease activity in patients with systemic lupus erythematosus].
Horák P; Hermanová Z; Faltýnek L; Pospísil Z; Scudla V
Vnitr Lek; 1997 Oct; 43(10):639-44. PubMed ID: 9601876
[TBL] [Abstract][Full Text] [Related]
8. The clinical significance of measuring different anti-dsDNA antibodies by using the Farr assay, an enzyme immunoassay and a Crithidia luciliae immunofluorescence test.
Werle E; Blazek M; Fiehn W
Lupus; 1992 Dec; 1(6):369-77. PubMed ID: 1304405
[TBL] [Abstract][Full Text] [Related]
9. Enzyme immunoassay for IgG and IgM antibodies against dsDNA and ssDNA.
Krippner H; Merle S; Pirlet K
Z Rheumatol; 1983; 42(5):256-60. PubMed ID: 6228081
[TBL] [Abstract][Full Text] [Related]
10. Anti-agalactosyl IgG antibodies and isotype profiles of rheumatoid factors in Sjögren's syndrome and rheumatoid arthritis.
Ichikawa Y; Yamada C; Horiki T; Hoshina Y; Uchiyama M; Yamada Y; Toumatu J
Clin Exp Rheumatol; 1998; 16(6):709-15. PubMed ID: 9844764
[TBL] [Abstract][Full Text] [Related]
11. A novel DNA/histone H4 peptide complex detects autoantibodies in systemic lupus erythematosus sera.
Panza F; Alcaro MC; Petrelli F; Angelotti F; Pratesi F; Rovero P; Migliorini P
Arthritis Res Ther; 2016 Oct; 18(1):220. PubMed ID: 27716380
[TBL] [Abstract][Full Text] [Related]
12. Anti-double stranded DNA antibodies in systemic lupus erythematosus: detection and clinical relevance of IgM-class antibodies.
Bootsma H; Spronk PE; Hummel EJ; de Boer G; ter Borg EJ; Limburg PC; Kallenberg CG
Scand J Rheumatol; 1996; 25(6):352-9. PubMed ID: 8996469
[TBL] [Abstract][Full Text] [Related]
13. The predictive value of fluctuations in IgM and IgG class anti-dsDNA antibodies for relapses in systemic lupus erythematosus. A prospective long-term observation.
Bootsma H; Spronk PE; Ter Borg EJ; Hummel EJ; de Boer G; Limburg PC; Kallenberg CG
Ann Rheum Dis; 1997 Nov; 56(11):661-6. PubMed ID: 9462168
[TBL] [Abstract][Full Text] [Related]
14. Anti-dsDNA antibody isotypes in systemic lupus erythematosus: IgA in addition to IgG anti-dsDNA help to identify glomerulonephritis and active disease.
Villalta D; Bizzaro N; Bassi N; Zen M; Gatto M; Ghirardello A; Iaccarino L; Punzi L; Doria A
PLoS One; 2013; 8(8):e71458. PubMed ID: 23951169
[TBL] [Abstract][Full Text] [Related]
15. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
[TBL] [Abstract][Full Text] [Related]
16. Anti-dsDNA antibodies and disease classification in antinuclear antibody positive patients: the role of analytical diversity.
Haugbro K; Nossent JC; Winkler T; Figenschau Y; Rekvig OP
Ann Rheum Dis; 2004 Apr; 63(4):386-94. PubMed ID: 15020332
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies to HMG-17 nucleosomal protein in autoimmune rheumatic diseases. Correlation with systemic lupus erythematosus clinical activity and with antibodies to double-stranded DNA.
Tzioufas AG; Boumba VA; Seferiadis K; Tsolas O; Moutsopoulos HM
Arthritis Rheum; 1993 Jul; 36(7):955-61. PubMed ID: 8318042
[TBL] [Abstract][Full Text] [Related]
18. A comparison of three anti-double stranded DNA antibody assays on sera from SLE and other diseases.
Clarke MC; Carr R; Burdash NM; Chen ZY; Ainsworth SK
Diagn Immunol; 1986; 4(6):288-93. PubMed ID: 3545632
[TBL] [Abstract][Full Text] [Related]
19. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus.
Amoura Z; Koutouzov S; Chabre H; Cacoub P; Amoura I; Musset L; Bach JF; Piette JC
Arthritis Rheum; 2000 Jan; 43(1):76-84. PubMed ID: 10643702
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies to lipoprotein lipase and dyslipidemia in systemic lupus erythematosus.
Reichlin M; Fesmire J; Quintero-Del-Rio AI; Wolfson-Reichlin M
Arthritis Rheum; 2002 Nov; 46(11):2957-63. PubMed ID: 12428237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]